MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2024)
Article in Frontiers in Molecular Biosciences (March 2024)
Article in Bioinformatics and Biology Insights (January 2024)